Lupus Nephritis

Edmund J. Lewis, M.D. is the Muehrcke Family Professor of Nephrology at Rush University Medical Center. Much of his career has been devoted to the study of immunopathologic mechanisms of glomerular disease, particularly lupus nephritis. He was an active participant in the International Study of Kidney Disease in Children (ISKDC), and as a member of the Pathology Committee he co-authored the first World Health Organization Classification of lupus nephritis. This led him to organize the Collaborative Study Group, whose initial study of plasmapheresis in severe lupus nephritis led to many important observations regarding clinical and histologic features which determine response to therapy in this patient population. In 2007, Dr. Lewis received the Belding Scribner Award of the American Society of Nephrology "for outstanding contributions to nephrology in the area of clinical practice and patient care".


Professor Melvin M. Schwartz completed his M.D. at the University of Minnesota in 1967, before taking a Pathology Residency at the Mallory Institute of Pathology between 1968 and1971, and completing a Renal Pathology Fellowship, also at the Mallory Institute of Pathology, in 1973. He became Professor Pathology at Rush University Medical Center in1984.


Stephen M. Korbet graduated from Rush Medical College in 1979 and did his internship, residency and Fellowship training at Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois. He is board certified in Internal Medicine and Nephrology. Dr. Korbet has received many prestigious honors and awards. He holds the endowed chair of the "Lester and Muriel Anixter Professor of Nephrology" at Rush Medical College. He is also currently the Medical Director of Circle Medical Management Dialysis Facility in Chicago as well as the Division Chief of the Section of Nephrology, Rush University Medical Center. Chicago, IL He has also been actively involved in clinical research involving kidney disease and dialysis since 1986 until the present date.

Tak Mao Daniel Chan graduated from the University of Hong Kong in 1985, and received training in nephrology and internal medicine in Hong Kong and at the Guy's Hospital in London, U.K. He is a Fellow of the Royal Colleges of Physicians in U.K. He is currently Personal Chair and Yu Foundation Endowed Professor in Nephrology at the Department of Medicine, and the Associated Dean at the Li Ka Shing Faculty of Medicine, University of Hong Kong. He was President of the Asian Pacific Society of Nephrology from 2008 to 2010. He is an Executive Committee member of the Asian Society of Transplantation, and has previously served as President of the Hong Kong Society of Transplantation. He pioneered the use of mycophenolate mofetil in the treatment of severe lupus nephritis. In addition to the treatment and immuno-pathogenesis of lupus nephritis, his other research interests include viral hepatitis in patients with renal failure.